Development of UTX-121 and its derivatives as novel matrix metalloproteinase-2/9 inhibitors using celecoxib as a lead compound

• Material Type: 博士論文
• Title: Development of UTX-121 and its derivatives as novel matrix metalloproteinase-2/9 inhibitors using celecoxib as a lead compound
• Author/Editor: 山花, 啓梨
• Author Heading: 山花, 啓梨
• Publication Date: 2022-03-01
• Publication Date (W3CDTF): 2022-03-01
• Alternative Title: Celecoxibをリードとした新規MMP-2/9阻害剤UTX-121およびその誘導体の開発
• Degree Grantor: 徳島大学
• Date Granted: 2022-03-01
• Date Granted (W3CDTF): 2022-03-01
• Dissertation Number: 甲先第418号
• Degree Type: 博士（工学）
• Conferring No. (Dissertation): 甲第3576号
• Text Language Code: eng
• Subject Heading: matrix metalloproteinase-2/9; celecoxib; antitumor; antimetastasis
• Target Audience: 一般
• Note (General): 出版タイプ： NA
• Persistent ID (NDL): info:ndljp/pid/12263336; https://dl.ndl.go.jp/pid/12263336
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2022-05-09T11:57:37+09:00
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): https://tokushima-u.repo.nii.ac.jp/records/2009841
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

• Summary, etc.: Matrix metalloproteinases (MMP)-2/9 are closely associated with cancer malignancy, and it has been considered that the inhibition of these MMPs may be...